Big Pharma Banks on Fatty Liver Disease

Fatty liver disease is NOT an uncommon issue, and isn't just impacting those who are exposed to excess alcohol or toxins. Non-alcoholic fatty liver disease is a condition associated with obesity, which impacts a continuously increasing amount of our population. Drug developers, of course, are looking to make a buck. But what can you do from a natural perspective to support liver health? Lots!  https://www.clinicaleducation.org/news/big-pharma-banks-on-fatty-liver-disease/